pembrolizumab,lenvatinib
merck,eisai
['keytruda', 'lenva', 'leap002', 'pembro', 'lenvima', 'eisai', 'merck', '$mrk']
#merck and #eisai present results from phase 3 #leap002 trial evaluating #keytruda (#pembrolizumab) plus #lenvima (#lenvatinib) versus #lenvimamonotherapy in patients with unresectable #hepatocellularcarcinoma #esmo22 $mrk 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.